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Embryonic stem cells (ESC) have the potential to generate all the cell lineages that 
will form the body. However, the molecular mechanisms underlying ESC 
differentiation and especially the role of alternative splicing in this process remain 
poorly understood. Here, we show that the alternative splicing regulator Mbnl1 
promotes the generation of the atypical calcineurin A variant CnAβ1 in mouse 
ESCs (mESC). CnAβ1 has a unique C-terminal domain that drives its localization 
mainly to Golgi apparatus by interacting with Cog8. CnAβ1 regulates the 
intracellular localization and activation of the mTORC2 complex. CnAβ1 
knockdown results in delocalization of mTORC2 from the membrane to the 
cytoplasm, inactivation of the AKT/GSK3β/-catenin signaling pathway and 
defective mesoderm specification. In summary, we unveil here the structural basis 
for the mechanism of action of CnAβ1 and its role in the differentiation of mESCs to 
the mesodermal lineage. 
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Introduction 
Embryonic stem cells (ESCs) have the ability to proliferate indefinitely in culture, 
and to differentiate into all embryonic lineages. Although the transcriptional 
program that coordinates pluripotency has been progressively unveiled during the 
past few years (Hackett and Surani, 2014; Kumar et al., 2014), the signaling 
pathways that regulate early differentiation events are not completely understood.  
Calcineurin (Cn) is a calcium/calmodulin-dependent serine/threonine 
phosphatase composed of two subunits: a catalytic A subunit (CnA) and a 
regulatory B subunit (CnB) (Li H et al., 2011). Activation of CnA catalytic activity is 
mediated by CnB and calmodulin in response to an increase in intracellular 
calcium. Three CnA genes have been described in higher vertebrates: CnAalpha 
(CnAα) and CnAbeta (CnAβ), which are ubiquitously expressed, and CnAgamma 
(CnAγ), which is confined to brain and testis. All CnA isoforms share the same 
functional domains, including a catalytic domain, a CnB-interacting domain, a 
calmodulin binding region and an autoinhibitory domain that maintains the enzyme 
in an inactive conformation in the absence of calcium. Interestingly, an alternative 
splicing variant of CnAβ has been described that lacks the autoinhibitory domain 
present in all other naturally occurring Cn isoforms (D Guerini and Klee, 1989; 
Lara-Pezzi et al., 2007). This alternatively spliced CnAβ isoform was termed 
CnAβ1, as opposed to the predominant CnAβ2 isoform, and is the result of the 
retention of intron 12-13, which gives rise to a unique C-terminal domain not 
present in any other known protein (Fig. 1A). Unlike other calcineurin isoforms, 
CnAβ1 has no impact on NFAT-regulated genes and instead activates the AKT 
Regulation of mesoderm specification by CnAβ1 Gómez-Salinero et al. 
Page 5 of 36 
 
signaling pathway through its interaction with the mTORC2 complex, which 
phosphorylates AKT in S473 (Felkin et al., 2011; López-Olañeta et al., 2014). In 
myoblasts, CnAβ1 prevents differentiation by activating AKT (Lara-Pezzi et al., 
2007), whose activation has also been reported to regulate both ESC pluripotency 
and differentiation (Naito et al., 2005; Watanabe et al., 2006). CnAβ1 is strongly 
expressed in regenerating tissues and progenitor cells (Lara-Pezzi et al., 2007), 
however its role in embryonic stem cells and its mechanism of action are unknown. 
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Results 
CnAβ1 is necessary for mesoderm differentiation 
We observed that the expression of CnAβ1 is significantly increased in mouse 
embryonic stem cells (mESCs) compared to adult differentiated tissues, whereas 
CnAβ2 shows an opposite expression pattern (Fig. 1B-D). To investigate the role of 
CnAβ1 in mESCs, we downregulated CnAβ1 expression with two specific siRNAs 
that have no effect on the expression of other CnA isoforms (Fig. S1A-F). 
Microarray analysis showed no effect of CnAβ1 knockdown on mESCs in 
pluripotent conditions, with no gene function significantly affected 48 h after siRNA 
transfection (Table S1). These results were validated by RT-PCR analysis, which 
showed no change in the expression of the pluripotency related genes Oct3/4, Klf4, 
Sox2, Gbx2 and Stela (Fig. S1G-K), suggesting that CnAβ1 is not necessary for 
the maintenance of pluripotent conditions in mESCs. 
We next analyzed the expression of the different CnA isoforms during mESC 
differentiation. Interestingly, we found that CnAβ1 expression was significantly 
upregulated during early differentiation to mesoendoderm but not to ectoderm (Fig. 
1E and F), whereas expression of CnA2 was increased during differentiation to 
both lineages (Fig. 2SA and B). It has been recently described that muscleblind like 
(Mbnl) proteins are major splicing regulators in ESCs that repress pluripotency and 
promote differentiation (Han et al., 2013). To investigate the potential regulation of 
CnA splicing by Mbnl1, we first explored available CLIP-Seq datasets for this 
trans-regulatory factor obtained from myoblasts and differentiated tissues (Wang et 
al., 2012). These datasets have been previously used to identify Mbnl1 targets 
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shared between C2C12 and mESCs (Han et al., 2013). We identified two Mbnl1 
binding sites in CnA’s intron 12-13 in C2C12 myoblasts that were absent in adult 
differentiated tissues (Fig. 1G). The presence of Mbnl1 binding marks in C2C12 
cells correlates with CnAβ1 expression, which is higher in myoblasts than in fully 
differentiated tissues (Lara-Pezzi et al., 2007). To determine the role of Mbnl 
proteins in the regulation of CnAβ1 in mESCs we downregulated both Mbnl1 and 
Mbnl2 using previously reported siRNAs (Han et al., 2013) (Fig. 1G). Mbnl1 
knockdown resulted in a significant downregulation of CnAβ1 expression without 
altering CnAβ2 levels, whereas Mbnl2 knockdown had no effect on either 
calcineurin isoform (Fig. 1H and I), suggesting that Mbnl1 regulates CnAβ1 
expression. 
To study the role of CnAβ1 in early mESCs differentiation, we transfected 
mESCs with CnAβ1 siRNAs and induced them to differentiate to mesoderm by 
using embryoid bodies (EBs). Microarray analysis 48 h after transfection showed a 
selective downregulation of several genes involved in mesoderm specification (Fig. 
S3A; Tables S2 and S3), that was confirmed by qRT-PCR (Fig. S3B). To further 
investigate the role of CnAβ1 in this process, we allowed the cells to differentiate 
for 2, 4 and 6 days after CnAβ1 siRNA transfection. We observed that CnAβ1 was 
significantly downregulated at day 2 post-transfection and recovered normal levels 
by day 4 following siRNA clearances (Fig. 2A). In agreement with our microarray 
results we found a significant downregulation of the mesoendoderm specification 
markers BraT, Gsc, Eomes, Mesp1 and Sox17 at day 4 of differentiation in the 
CnAβ1 siRNA group (Fig. 2B-F) that was already evident at day 2. We found no 
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differences in the expression of the pluripotent gene Sox2 and the neuroectoderm 
differentiation marker Nestin (Fig. 2G and H).  
To determine whether the defective mESC differentiation observed in the 
presence of CnAβ1 siRNAs could be a consequence of reduced proliferation, we 
grew the cells in the presence of BrdU for 4 h, starting 44 h after siRNA 
transfection. As shown in Fig. S3C, we found no significant differences in BrdU 
incorporation between control and CnAβ1 knockdown, suggesting that the defect in 
differentiation was not due to lack of proliferation. 
 
CnAβ1 regulates mesoderm specification through AKT, GSK3 and β-catenin 
We have previously shown that CnAβ1 regulates AKT phosphorylation (Felkin et 
al., 2011; López-Olañeta et al., 2014). To investigate whether CnAβ1 is controlling 
this pathway during mESC differentiation we knocked down CnAβ1 and induced 
the mESCs to differentiate to mesoderm. Western blot analysis showed decreased 
phosphorylation of AKT in the samples treated with CnAβ1 siRNAs (Fig. 3A and B), 
indicating reduced AKT activation. AKT has been reported to regulate mesoderm 
differentiation by phosphorylating and inhibiting GSK3β, which is involved in the 
sequestration and degradation of β-catenin (Naito et al., 2005). We found that 
GSK3β phosphorylation was reduced after CnAβ1 knockdown, indicating 
increased GSK3 activation and leading to decreased β-catenin levels. This 
reduction in β-catenin expression was accompanied by a decrease in -catenin-
dependent transcription in cells transfected with CnA1 siRNAs and a luciferase 
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reporter vector carrying a multimer of a TCF binding motif that is activated by β-
catenin (TOP-Luc, Fig. 3C).  
To confirm the role of GSK3 in the reduction of mESC differentiation caused 
by CnAβ1 siRNAs, we inhibited GSK3 activity by treating cells with LiCl for 8 h 
starting on the second day of differentiation. We allowed differentiation to proceed 
until day 4 and analyzed the expression of several mesoendoderm differentiation 
markers. As previously observed, CnAβ1 inhibition resulted in the downregulation 
of mesoendoderm genes at day 4 of differentiation (Fig. 3D). Interestingly, this 
effect was prevented when GSK3 was inhibited with LiCl. Together, our results 
unveil an important role of CnAβ1 in early mesoendoderm specification by the 
control of the AKT/GSK3/-catenin axis.     
It has been previously described that the regulatory subunit of calcineurin 
(CnB) is required for the proper differentiation of mESCs through the activation of 
NFAT (Li X et al., 2011). To confirm that the activation of the AKT pathway is 
specific to the CnAβ1 isoform, we investigated the role of CnAβ2 during 
differentiation. As expected, CnAβ2 knockdown resulted in decreased expression 
of mESCs differentiation makers (Fig. S4A-H). However, unlike with CnAβ1, this 
effect seemed independent of the AKT/GSK3/β-catenin pathway, which was not 
affected by CnA2 siRNA treatment (Fig. S5A and B). Furthermore, chemical 
inhibition of the catalytic activity of all CnA isoforms using cyclosporin A (CsA) 
resulted in reduced mesodermal differentiation of mESCs with no effects on the 
AKT pathway (Fig. S5C-E). 
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CnA1 and CnA2 have a distinct intracellular distribution 
Previous reports have suggested that the activation of Akt by mTOR occurs in the 
cell membranes (Zhao et al., 2015). However, it is not entirely clear how this 
signaling pathway is activated and, more specifically, how it is triggered by CnAβ1. 
To determine whether the intracellular distribution of CnAβ1 coincided with that of 
mTOR, we purified enriched fractions of cytoplasm and membranes extracts from 
mESCs and analyzed the distribution of CnAβ1 and CnAβ2. Surprisingly, we found 
CnAβ1 enriched in the membranes fraction together with membrane bound 
proteins like integrin β1 and GM130 (Fig. 4A), whereas CnAβ2 was mainly present 
in the cytoplasm. The mTORC2 components Rictor and mTOR were also enriched 
in the membranes fraction, as was the auto-phosphorylated form of mTOR at 
S2481, associated with activation of the mTORC2 complex (Copp et al., 2009).  
 To investigate whether CnAβ1 was necessary for the activation of the 
mTORC2 complex we analyzed the distribution of mTOR and Rictor after knocking 
down CnAβ1. Interestingly, we found that CnAβ1 downregulation resulted in a 
partial delocalization of phospho-mTOR and Rictor from the membranes to the 
cytoplasm fraction (Fig. 4B and C). These results suggest that CnA1 is necessary 
for mTORC2 localization and activation at the membranes. 
 
The C-terminal region in CnAβ1 drives its localization to intracellular membranes 
The role and structural characteristics of CnAβ1's C-terminal unique domain are 
not completely understood. We used Psipred to predict its secondary structure and 
found that CnAβ1's C-terminal domain contains two different α-helixes 
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corresponding to two highly conserved motifs that may confer CnAβ1 distinct 
biological properties (Fig. S6A and B). 
To determine the role of the C-terminal domain and its two -helices, we 
produced chimeras of different regions of CnAβ1 or CnAβ2 fused to EGFP. We 
transfected the different constructs into P19 cells and found a completely different 
localization of CnAβ1 and CnAβ2 within the cell. Whereas CnAβ2 was 
homogenously distributed throughout the cytoplasm, CnAβ1 was mainly localized 
in the Golgi apparatus, as shown by co-localization with the cis-Golgi marker 
GM130 (Fig. 5A). This localization was reproduced by a chimera carrying just the 
C-terminal domain of CnAβ1 linked to GFP, but not by one bearing the 
autoinhibitory domain of CnAβ2. To determine whether this specific localization is 
driven by any of the two -helices in the C-terminal domain of CnAβ1, we linked 
each -helix to GFP separately. We observed that the localization in the Golgi 
apparatus was only maintained in the chimera bearing the second -helix. 
Changes in the subcellular localization of each construct were quantified and 
shown as percentage of cells with localization in the Golgi apparatus (Fig. 5D). 
These results support the existence of two different evolutionarily conserved -
helices with distinct properties in the C-terminal domain of CnAβ1.  
Interestingly, we found a short aminoacid sequence (ACREFLL) in the 
second -helix that is similar to a motif (AIREFLF) present in an mTOR domain 
that directs its localization to the Golgi apparatus (Liu and Zheng, 2007). To 
determine the role of this motif in CnAβ1, we substituted these aminoacids by 
others of a similar group and size (VSKDLFF) in the GFP-CnAβ1 construct 
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(CnAβ1-mut). Transfection of p19 cells with this construct showed a disperse 
CnAβ1-mut localization and low co-localization with GM130, compared to the wild 
type CnAβ1 construct (Fig. 5B and C). Importantly, mTOR co-precipitated with 
GFP-CnAβ1, whereas it failed to interact with GFP-CnAβ1-mut (Fig. 5E), 
suggesting that CnAβ1's C-terminal domain defines both its localization and its 
interaction partners. 
 
Cog8 drives the localization of CnAβ1 to the Golgi apparatus 
To gain further insight into the mechanisms driving this localization, we carried out 
a yeast two hybrid screening. In addition to known CnA interacting proteins like 
CnB (Felkin et al., 2011), we identified the interaction between CnAβ1 and Cog8, a 
protein enriched mainly in the external Golgi as well as other intracellular 
membranes that is involved in the interaction with the Cog and SNARE complexes 
(Laufman et al., 2013; Willett et al., 2013; Willett et al., 2014) (Table S4). To 
validate this interaction, we transfected cells with GFP-CnAβ1 chimeras and 
carried out immunoprecipitation and colocalization experiments. As shown in Fig. 
6A, Cog8 co-precipitated with GFP-CnAβ1 but not with GFP-CnAβ1-mut. In 
addition, GFP-CnAβ1 showed a strong colocalization with Cog8 in P19 cells (Fig. 
6B). To determine whether this interaction is necessary for the localization of 
CnAβ1 in the Golgi, Cog8 was downregulated by transfecting two independent 
siRNAs into P19 cells together with the GFP-CnAβ1 chimera (Fig 6C-E). We 
observed that GFP-CnAβ1 was delocalized from the Golgi after Cog8 knockdown, 
confirming that the interaction with Cog8 is necessary for the subcellular 
localization of CnAβ1. 
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To characterize the function of Cog8 in mESCs differentiation, we 
downregulated its expression and analyzed different mesodermal expression 
markers after early differentiation. Although Cog8 siRNAs were only functional 
during the first 48 hours (Fig. 7A), we found a significant downregulation of the 
mesodermal differentiation markers BraT, Gsc and Eomes at day 4 (Fig. 7B-D), in 
agreement with the results obtained after CnAβ1 knockdown. 
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Discussion 
Here we provide insight into the mechanism of action of the calcineurin A beta 
splicing variant CnAβ1 and its role in mESC differentiation. Our results show that a 
novel motif in the alternative C-terminal domain of CnAβ1 drives its localization to 
the Golgi apparatus, where it serves as a scaffold for the activation of the 
mTOR/AKT signaling pathway. Activation of this pathway is unique to this CnA 
isoform, since cyclosporin treatment or CnA2 downregulation have any effect on 
it. 
The activation of the AKT pathway is thought to involve prior auto-
phosphorylation of mTOR at S2481 within the mTORC2 complex (Copp et al., 
2009), although the precise mechanism behind this auto-activation is still unclear. 
mTORC2 activation leads to subsequent phosphorylation and activation of AKT at 
S473 (Copp et al., 2009). Different components of mTORC2 have been described 
to localize at intracellular membranes (Betz and Hall, 2013; Liu and Zheng, 2007; 
Yuan et al., 2015), although the role and mechanisms regulating this localization 
are also not fully understood. Our work suggests that the localization and activation 
of mTORC2 at the cell membranes depends, at least in part, on CnA1. Loss of 
CnAβ1 results in delocalization of mTOR, Rictor and the auto-phosphorylated form 
of mTOR to the cytoplasm as well as a decreased AKT activation. AKT activation 
has been previously linked to its recruitment to the cellular membranes (Zhao et 
al., 2015). Therefore, our data suggest that AKT activation might be regulated by 
mTORC2's subcellular localization. Interestingly, the motif necessary for the 
localization of CnAβ1 at the Golgi apparatus is similar to a motif found in the 
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domain responsible for mTOR’s localization at the Golgi (Liu and Zheng, 2007), 
suggesting a common regulatory mechanism. Loss of this motif in CnAβ1 results in 
delocalization of the protein and loss of its interaction with mTOR. These results 
suggest that CnAβ1 may be acting as an adaptor protein that recruits mTORC2 to 
specific intracellular membranes to facilitate its activation and the subsequent 
activation of the AKT pathway. 
The role of Akt in mESC is controversial, with some reports  implicating it in 
pluripotency and others suggesting its involvement in differentiation (Naito et al., 
2005; Niwa et al., 2009). This differential role might be associated to the regulation 
of AKT by different complexes (Guertin et al., 2006). Similar results have been 
described for β-catenin in mESC, where it has opposite effects depending on the 
complex it binds to (Miyabayashi et al., 2007). In this regard, we have not observed 
any contribution to pluripotency maintenance by CnAβ1, whereas we found a 
significant downregulation of ESC differentiation towards the mesoderm lineage 
after CnAβ1 depletion. Considering that CnAβ1 is necessary for activation of the 
AKT/GSK3/β-catenin pathway and that AKT has been reported to be involved in 
ESC differentiation (Naito et al., 2005), our results suggests that the inactivation of 
AKT is the main reason behind the defective mesodermal differentiation observed 
after CnAβ1 knockdown. Interestingly, Cog8 knockdown, which delocalizes CnAβ1, 
also results in defective mesodermal differentiation. These results reinforce the 
notion that activation of AKT and its targets in different subcellular domains may 
contribute to their role in ESC pluripotency and differentiation.   
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We also provide insight into the regulation of CnA post-transcriptional 
processing that leads to expression of CnAβ1. We show for the first time that CnA 
splicing is controlled, at least in part, by Mbnl1, which has a similar role to that of 
CnAβ1 in the differentiation of ESCs (Han et al., 2013).  Mbnl1 was previously 
shown to favor ESC differentiation by controlling AS of different genes. 
Interestingly, the inhibition of Mbnl1/2 in somatic cells improves the efficiency of 
iPSCs reprogramming (Han et al., 2013), further confirming their role in the 
maintenance of a differentiation phenotype. Mbnl1 expression is increased upon 
differentiation of ES and myoblast C2C12 cells and it shows similar mRNA targets 
in both cell types (Han et al., 2013; Wang et al., 2012). CnAβ1 follows a similar 
expression pattern and its regulation by Mbnl1 suggests it could be part of a larger 
pathway involved in the control of early cell differentiation. Interestingly, reduced 
activation of Akt and mTOR targets has been described after Mbnl loss of function 
in human ES-derived neural stem cells (Denis et al., 2013), further suggesting that 
Mbnl1 and CnAβ1 are involved in common pathways. 
 Alternative splicing of CnA results in the retention and translation of intron 
12-13 into a unique C-terminal domain that confers CnAβ1 specific localization and 
function.  We describe here the presence of two evolutionarily conserved -helixes 
in the C-terminal domain of CnAβ1 that have different functions. We show that the 
second -helix is necessary and sufficient to drive its localization to the intracellular 
membranes of the cell, mainly to the Golgi apparatus. This localization depends on 
the interaction of CnAβ1 with Cog8. Cog8 is an important player in the stabilization 
of the Cog and SNARE complexes required for the tethering and transport of 
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vesicles to the Golgi, and in the regulation of the proper compartmentalization of 
Golgi proteins (Laufman et al., 2013; Willett et al., 2013). The localization at the 
Golgi apparatus is specific of CnAβ1 and suggests that this calcineurin isoform 
plays a different role from that of CnAβ2, which is distributed throughout the 
cytoplasm of the cell.  
The role of calcineurin itself in ESC differentiation is also unclear. It has 
been reported that the calcineurin regulatory subunit CnB, which binds to all CnA 
isoforms, is necessary for mESC differentiation to all lineages through a 
mechanism involving the transcription factor NFAT (Li X et al., 2011). In contrast, a 
recent work suggests that CnB activity may be specifically needed for ectoderm 
differentiation, but dispensable for mesoderm and endoderm differentiation, and 
that CnA controls BMP signaling by directly targeting Smad1/5 during this process 
(Cho et al., 2014). Knockout mice lacking the catalytic domain in CnA are born at 
normal mendelian ratios (Bueno et al., 2002), suggesting that the phosphatase 
activity of CnA is not essential for mESC differentiation. It has also been 
described that the CnA inhibitor Cyclosporine A  (CsA) enhances cardiomyocyte 
differentiation (Jansen Of Lorkeers et al., 2014). However, this effect might be 
related to other actions of CsA, which inhibits calcium release through the 
mitochondrial pore. In this context, we show here that CnAβ1 is necessary for 
mesodermal differentiation likely by activating -catenin-mediated transcription 
through the activation of AKT and subsequent inhibition of GSK3. CnA2 
knockdown and inhibition of CnA catalytic activity with CsA result in a similar defect 
in mesodermal differentiation to that observed for CnAβ1, although, unlike the 
Regulation of mesoderm specification by CnAβ1 Gómez-Salinero et al. 
Page 18 of 36 
 
latter, they have no effect on the AKT/GSK3/-catenin axis. Together, these results 
suggest that different CnA isoforms contribute to ESC differentiation through 
different pathways (Fig. S7). 
In summary, we reveal a novel mechanism regulating ESC differentiation 
that involves the alternatively spliced CnAβ1 isoform. By binding to Cog8, CnAβ1 
acts as a scaffold in the Golgi apparatus, where it regulates the mTORC2 complex 
localization and is necessary for the activation of the AKT/GSK3β/-catenin 
pathway. These results may have implications for the control of ESC differentiation 
in regenerative medicine and for the treatment of diseases in which this pathway is 
strongly activated, such as cancer. 
 
Significance 
Alternative splicing generates different proteins from a single transcript through the 
inclusion or exclusion of certain exons and introns, which often results in changes 
in protein interactions, structure, localization and/or function. Importantly, 
alternative splicing has been associated with the regulation of different cellular 
processes including cell differentiation. However, the precise molecular 
mechanisms underlying this regulation remain poorly understood. We have 
observed that the calcineurin A gene produces two variants that differ in their C-
terminal domain (CnAβ1 and CnAβ2). Both of them control mouse embryonic stem 
cell differentiation through complementary mechanisms. The atypical CnAβ1 
variant is localized at the Golgi apparatus, in contrast to other calcineurin isoforms, 
which are localized in the cytoplasm. This localization is mediated by an alpha helix 
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in its alternative C-terminal domain, which is necessary for the interaction with 
mTORC2 and for the localization and activation of this complex at the membranes 
of the cell. CnAβ1 activates the AKT/GSK3β/-catenin signaling pathway 
downstream of mTORC2 to promote mouse embryonic stem cell differentiation. 
The localization of CnAβ1 at the Golgi is regulated by the interaction between its C-
terminal domain and the Golgi protein Cog8. Interestingly, both CnAβ1 and Cog8 
are required for the differentiation of mouse embryonic stem cells, further 
confirming the importance of in the localized regulation of this pathway for this 
cellular process. In summary, we unveil here the structural basis for the 
mechanism of action of CnAβ1 and its role in the differentiation of mESCs to the 
mesodermal lineage. 
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Complete experimental procedures can be found in the online supplement. 
 
Cell culture and transfection 
R1 mESCs in pluripotent conditions were grown on irradiated mouse embryonic 
fibroblast (MEFs) in Dulbecco’s modified Eagle medium (DMEM) supplemented 
with L-glutamine (2 mM), NEAA (1X), β-Mercaptoethanol (50 μM), 15% high 
qualified FBS and LIF at 37 ºC in a 5% CO2 atmosphere. mESCs were passaged 
every 2 days in pluripotent conditions using Trypsin (Sigma). For differentiation 
assays, mESCs were trypsinized and cultured first for 1 h under pluripotent 
conditions in 0.1% gelatin coated dishes to discard MEFs. We used the hanging 
drop method for mesoendoderm differentiation with a cell suspension of 5x104 
cell/ml (1000 cells per drop in 20 μl) in DMEM supplemented with L-glutamine (2 
mM), NEAA (1X), β-Mercaptoethanol (50 μM) and 20% FBS as previously 
described (Bondue et al., 2008). On day 2 of differentiation the EBs where 
collected, cultured on an untreated dish for 5 d and further cultured on a 0.1% 
gelatin-coated dish. Neural progenitor cell differentiation was induced using DMEM 
supplemented with L-glutamine (2 mM), NEAA (1X), β-Mercaptoethanol (50 μM) 
and 10% knockout serum replacement (Kamiya et al., 2011).  
mESCs were transfected in suspension with Lipofectamine 2000 (Invitrogen) and 
10 μM siRNAs (Table S5) or 1 μg of modified RNA (Bernal, 2013; Pankaj K Mandal 
and Rossi, 2013) following the manufacturer’s instructions. A luciferase siRNA and 
a GFP modified RNA were used as negative controls, respectively. After 
transfection, cells were collected and differentiated to mesoendoderm or 
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maintained under pluripotent conditions. The inhibition of GSK3β was performed as 
previously described (Lindsley et al., 2006). Briefly mESCs were transfected with 
CnAβ1 or control siRNAs and differentiated in EBs. At day 2 of differentiation 20 
μM LiCl was added for 8 h in differentiation medium to inhibit GSK3β. Cells were 
then changed to normal differentiation medium. The expression of the 
differentiation markers was analyzed at day 4 and compared to its expression in 
the control cells.  The inhibition of calcineurin was performed using Cyclosporin A 
(CsA) at 200 ng/mL. Cells were differentiated on the presence or absence of CsA 
on the second day of differentiation for 8 hours and analyzed by western blot or 
differentiated until day 4 on the presence or absence of CsA and the expression of 
the differentiation markers was analyzed. 
P19 cells were maintained in DMEM supplemented with L-glutamine (2 mM), β-
Mercaptoethanol (50 μM) and 10% FBS. P19 cells were transfected in suspension 
with Lipofectamine 2000 on 1% gelatin-coated coverslips following the 
manufacturer’s instructions. Cells were fixed in 4% paraformaldehyde (PFA) 24 h 
after transfection. To study the localization of CnAβ1 after Cog8 knockdown, we 
transfected the cells for 2 days with Cog8 siRNAs (Table S6) to downregulate its 
expression, and then transfected the GFP-CnAβ1 construct. Cells were fixed 6 h 
post-transfection and immunostained for GFP, Cog8 and GM130 using specific 
antibodies. 
 
RNA isolation and qRT-PCR  
Regulation of mesoderm specification by CnAβ1 Gómez-Salinero et al. 
Page 22 of 36 
 
Total RNA was isolated from mESCs with RNeasy Mini Kit (Qiagen). First-strand 
cDNA was synthesized using 100 ng total RNA and a High Capacity cDNA 
Reverse Transcription kit (Applied Biosystems). The cDNA was amplified using the 
primers described in Table S7. Quantitative RT-PCR was carried out in an Applied 
Biosystems 7900 Fast real-time PCR system (Applied Biosystems) using SYBR 
green for double-stranded DNA detection and quantification or TaqMan probes as 
indicated in Table S7, S8. Results were analyzed with LinReg PCR software 
(Ruijter et al., 2013). Values were normalized to GAPDH or 18S TaqMan probes. 
   
CLIP-Seq Analysis and RNA-Seq alignment 
Bed file alignments from the GSE39911 dataset were downloaded from Gene 
Expression Omnibus (GEO) and aligned to the mm9 genome using IGV software. 
The localization of the Mbnl1 binding sites in CnAβ (Ppp3cb) was identified in 
C2C12 myoblasts, C57/Bl6 heart, muscle and brain samples. Raw sequencing 
data for brain, heart, and muscle samples from wild-type mice (5 replicates per 
tissue) and C2C12 mouse myoblasts (single control sample) were retrieved from 
the NCBI Short Read Archive (SRA study accession number SRP014709) and 
converted to FASTQ using fastq-dump in SRA Toolkit version 2.3.3-2. Reads were 
aligned with TopHat2 version 2.0.12 to the GRCm38 mouse genome using 
available transcript annotations from Ensembl release 76 (Gatto A et al., 2014). For 
paired-end data (C2C12 control sample) the mean insert size and standard 
deviation were computed empirically from uniquely mapping, perfect matching 
mate pairs via a preliminary alignment with Bowtie2 version 2.2.3 and supplied as 
input parameters to TopHat2. Default options were used otherwise. Reads 
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mapping to the genomic location spanning the last four exons of the calcineurin 
gene (chromosome 14: 20,499,364-20,509,500 reverse strand) were retrieved after 
sorting and indexing the corresponding BAM files with samtools version 1.0 (Li H et 
al., 2009). Custom Python scripts were used to compute per-base coverage, 
normalize raw counts to the maximum over the specified region and plot the 
relative read distribution (median over 5 replicates in tissue samples) against 
calcineurin terminal exons. 
 
Microarray Analysis  
mESCs were transfected with siRNAs against CnAβ1 or a control siRNA targeting 
luciferase and analyzed 48 h later in pluripotent or differentiation conditions. 
Microarray analysis was performed on 8 samples: 3x control siRNA, 3x CnAβ1 
siRNA #1 and 2x CnAβ1 siRNA #2. Labelling and hybridization to Affymetrix 
Mouse Gene 1.0 ST Arrays (Mouse) for mESCs in pluripotent conditions, or Agilent 
Whole Mouse Genome Microarray 4x44K v2 for mESCs in differentiation 
conditions was carried out at CNIC Genomics Unit. Normalization and analysis of 
the data were performed using GeneSpring software. Gene Ontology (GO) 
analysis was performed using David Bioinformatics. GO results were considered 
significant at p<0.05. The entirety of the Microarray data set has been supplied to 
the Gene Expression Omnibus public database (Series GSE72103).  
 
Western Blot  
EBs were homogenized in lysis buffer (150 mM NaCl, 1% IGEPAL, 0.5% sodium 
deoxycholate, 0.1% SDS, and 50 mM Tris pH 8.0) in the presence of protease and 
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phosphatase inhibitors (04693159001 and 04906845001 Roche Diagnostics). EB 
lysates were separated in SDS-PAGE gels, transferred to PVDF membranes and 
blocked with 3% non-fat dry milk in PBS for 30 min. The membranes were 
incubated with primary antibodies overnight, followed by appropriate HRP-labelled 
secondary antibodies (anti-mouse P0447 and anti-rabbit P0448, Dako). HRP 
activity was detected using a luminol-based reagent (RPN 2106, GE Healthcare). 
Primary antibodies: AKT (4691 Cell Signaling), p-AKT S473 (4058 Cell Signaling), 
GSK3β (9315 Cell Signaling), p-GSK3β (9323 Cell Signaling), β-actin (A5316 
Sigma), β-catenin (9562 Cell Signaling)., CnAβ1 (from our laboratory), Cog8 (PA5-
29126, Thermo), Vinculin (V4505, Sigma), Integrin 1 (MA1997, Millipore), RhoGDI 
(sc360, Santa Cruz), p-MTOR S2481 (2971 Cell Signaling), MTOR (2983 Cell 
Signaling), GM130 (bd610823 BD Biosciences), Rictor (ab56578 Abcam). Western 
blot quantification has been performed on ImageJ software. Brightness and 
contrast were linearly adjusted in Adobe Photoshop CS5.  
 
Luciferase assay 
mESCs were lysed in 1X passive lysis buffer (Promega) and homogenized for 15 
min at room temperature. Luciferase was measured following the manufacturer’s 
instructions (Promega) and normalized for transfection efficiency with Renilla 
luciferase. As a negative control, we used the same reporter plasmid with the TCF 
sites mutated (FOP-Luc) and expressed the results as the ratio of luciferase 
activity obtained with the TOP-Luc divided by the activity of the FOP-Luc.  
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Cytoplasm and membrane fractionation 
Cells were cultured under differentiation conditions and analyzed on the second 
day of differentiation. For the purification of enriched cytoplasmic or membrane 
fractions, the embryoid bodies were collected in PBS in the presence of protease 
and phosphatase inhibitors (04693159001 and 04906845001 Roche Diagnostics). 
Cells were then lysed in a homogenizer and centrifuged for 5 minutes at 3,000 g to 
remove the nuclei. The supernatant was centrifuged at 200,000 g to separate the 
membranes (pellet) from the cytoplasm (supernatant). Both fractions were 
analyzed by a western blot to verify their purity using antibodies against RhoGdI for 
the cytoplasm and against GM130 and integrin β1 for the membranes. 
 
DNA constructs  
pEGFP-CnAβ1, CnAβ2, the C-ter region of CnAβ1 and CnAβ2 and -helixes 1 and 
2 of CnAβ1 were amplified by PCR using KAPA HiFi HotStart Ready Mix PCR kit 
(Kapa Biosystems) from pCDNA3.1-based CnAβ1 and CnAβ2 constructs (Lara-
Pezzi et al., 2007) and inserted into pGEM-T vector. After the integrity of the 
constructs was confirmed by DNA sequencing they were cloned into the 
pEGFP.C3 vector in frame with GFP. The localization mutant CnAβ1-mut carries 
the following aminoacid mutations: ACREFLL > VSKDLFF. Modified mRNAs 
(modRNAs) were cloned and produced as previously described (Pankaj K Mandal 
and Rossi, 2013). Briefly the CDS of GFP (negative control), CnA1 or CnA1-mut 
were fused to a 3’ and a 5’ UTR that highly promote their expression, synthesized 
in vitro and purified.  
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P19 cells were transfected with the different GFP constructs and grown over-night 
on 1% gelatin-coated glass. Cells were fixed with 4% PFA/PBS for 10 min at 4 ºC, 
washed with PBS, permeabilized for 10 min with 0.1% Triton X-100/PBS and 
incubated in 10% Goat Serum/PBS for 30 min at room temperature. Cells were 
incubated overnight in 10% Goat Serum/PBS with anti-GFP (632592, Clontech 
(rabbit) or, 1010/0511FP12, Aves lab (chicken)), anti-GM130 (610823, BD 
Bioscience) or anti-Cog8 (PA5-29126, Thermo). After primary antibody incubation, 
cells were washed with PBS, incubated with Alexa Fluor 488 goat anti-rabbit IgG 
(A-11034, Thermo), Alexa Fluor 568 goat anti-mouse IgG (A-11004, Thermo), 
Alexa Fluro 488 goat anti-chicken IgG (A-11039, Thermo), Alexa Fluor 568 goat 
anti-rabbit IgG (A-11036, Thermo) or Alexa Fluor 633 goat anti-mouse IgG (A-
21126, Thermo) in 10% Goat Serum/PBT for 1 h at room temperature, and 
mounted in Vectashield Mounting medium with DAPI. Images were acquired in a 
Leica SPE3 confocal coupled to a DM 2500 microscope with an objective ACS 
APO 63.0X 1.13 OIL at 20ºC. The software used to acquire the images was LAS 
AF V 4.0.0 11706. The Manders’ correlation coefficient was calculated on ImageJ 
software performing the total green channel (GFP) over the red channel (GM130). 
Images were amplified and brightness and contrast were linearly adjusted using 
Adobe Photoshop CS5.  
 
Statistical analysis  
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All data are presented as mean ±SEM. All datasets were analyzed for statistical 
significance using 1-way ANOVA followed by Dunnett's post-test for multiple 
comparisons or 2-way ANOVA followed by Bonferroni's post-test (GraphPad 
Prism), as indicated in the figure legends. Changes were represented as 
statistically significant at p<0.05. 
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Figure Legends 
Figure 1. CnAβ1 expression is high in mESCs and is regulated by the 
splicing factor Mbnl1. (A) Schematic representation of the C-terminal region of 
CnAβ1 and CnAβ2. Arrows indicate the position of the primers used to analyze 
expression of each isoform. (B-D) CnAβ1 and CnAβ2 mRNA expression was 
quantified in mESCs and mouse adult tissues by qRT-PCR and normalized to the 
expression levels of CnAβ exons 2-3. Data are presented as fold induction over the 
relative expression of each isoform in mESCs (B and C) or as the ratio of CnAβ1 
over CnA2 (D). (E and F) CnAβ1 expression was analyzed by qRT-PCR in 
mESCs differentiated to mesoendoderm or ectoderm using an EB formation assay. 
(G) Fold CnAβ1 and CnA2 mRNA expression and Mbnl1 binding sites in their 3' 
UTRs (small black boxes) were determined by RNA-Seq and CLIP-Seq, 
respectively, in C2C12 myoblasts, adult mouse heart, muscle and brain 
(GSE39911). (H) Mbnl1 and Mbnl2 expression was analyzed 48 h after 
transfection with siRNAs for each isoform in mESCs differentiated to mesoderm. (I) 
mESCs were transfected with Mbnl siRNAs as in (H) and CnAβ1 and CnAβ2 
expression was determined 48 h after transfection by qRT-PCR. Results are 
presented as fold induction ±SEM over the values obtained with the control siRNA. 
*p<0.05, **p<0.01, ***p<0.001, one-way ANOVA with Dunnett’s post-test (A-F) or 
two-way ANOVA with Bonferroni post-test (H, I). n=3 for all experiments. 
 
Figure 2. CnAβ1 knockdown inhibits mesoendoderm differentiation. mESCs 
were transiently transfected with two different siRNAs for CnAβ1 or a control siRNA 
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and differentiated for 6 days towards mesoderm by using EBs. (A-H) RNA was 
extracted at different days of differentiation and CnAβ1, BraT, Eomes, Gsc, Mesp1, 
Sox17, Sox2 and Nestin expression was analyzed by qRT-PCR. Results are 
expressed as fold induction ±SEM over the values for undifferentiated stem cells. 
*p<0.05, **p<0.01, ***p<0.001, two-way ANOVA with Bonferroni post-test, n=3. 
 
Figure 3. CnAβ1 regulates the differentiation of mESC to mesoendoderm 
through β-catenin. (A) mESCs were transfected with CnAβ1 siRNAs and p-AKT 
S473, total AKT, p-GSK3β S9, total GSK3β, β-catenin and β-actin were analyzed 
by western blot at day 2 of differentiation. Molecular weights are indicated in kDa. 
(B) The signal intensity of p-AKT/total AKT, p-GSK3/total GSK3 and -catenin in 
the western blots was quantified and presented as fold induction ±SEM over the 
values of the control siRNA. (C) mESCs were transfected as in (A) along with a 
reporter vector in which luciferase expression is under the control of a multimer of 
TCF binding sites in tandem (TOP) or the same multimer with the TCF binding 
sites mutated (FOP). Results are expressed as the ratio ±SEM of TOP/FOP for 
each condition after normalization for transfection efficiency with Renilla luciferase. 
(D) mESC cells were transiently transfected with CnAβ1 siRNAs and differentiated 
through EBs towards mesoderm. Cells were treated for 8 h with 20 mM LiCl at day 
2 to inhibit GSK3. The expression of BraT, Eomes, Gsc and Sox17 was analyzed 
at day 4. Results are presented as fold induction ±SEM over the values of the 
control siRNA from each condition. *p<0.05, **p<0.01, ***p<0.005 one-way ANOVA 
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with Dunnett’s post-test, n=3 (B, C). *p<0.05 **p<0.01 two-way ANOVA with 
Bonferroni post-test, n=3 (D). 
 
Figure 4. CnAβ1 regulates mTORC2 localization and activation at cellular 
membranes. (A) mESCs were lysed using a homogenizer and separated into 
membrane and cytoplasm fractions. The localization of CnAβ1, CnAβ2, the 
mTORC2 components P-mTOR 2481, mTOR and Rictor, the cytoplasmic marker 
RhoGdI and membrane markers GM130 and integrin β1 was analyzed by western 
blot. (B, C) mESCs were transiently transfected with CnAβ1 siRNAs and 
differentiated to mesoderm. Forty-eight hours after siRNA transfection cells were 
lysed and homogenized to purify membrane (B) and cytoplasmic (C) fractions. The 
presence of CnAβ1, p-mTOR 2481 and Rictor was determined by western blot and 
normalized to the levels of the membrane and cytoplasmic markers GM130 and 
RhoGdI, respectively. Blots from 3 independent experiments were quantified and 
the average signal was expressed as fold induction ±SEM. *p<0.05, **p<0.01, two-
way ANOVA with Bonferroni's post-test 
 
Figure 5. CnAβ1 colocalizes with the Golgi apparatus using an evolutionarily 
conserved -helix in its C-terminal domain. (A) P19 cells were transfected with 
an expression vector carrying an EGFP chimera linked to full length CnAβ1 or 
CnAβ2 proteins, the C-terminal regions of CnAβ1 or CnAβ2, or each of the two -
helices in the CnAβ1 C-terminal region. Colocalization of all the constructs with the 
Golgi marker GM130 (red) was analyzed by immunofluorescence. Bar, 10 μm. (B) 
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P19 cells were transfected with a GFP chimera linked to full length CnAβ1 or 
CnAβ1-mut protein and colocalization with the Golgi marker GM130 (red) was 
analyzed by immunofluorescence. The mutated aminoacids in the CnAβ1-mut 
construct are indicated in red. Bar, 10 μm. (C) Manders’ colocalization coefficient 
analysis of the green channel over the red channel for both constructs in (B) was 
carried out using Jacob’s plugin from ImageJ. ***p<0.005, unpaired t-test, n=3. (D) 
The percentage of cells with GFP localization in the Golgi apparatus was 
quantified. At least 100 cells were counted for each condition. ***p<0.005, one-way 
ANOVA plus Bonferroni post-test, n=3. (E) 293T cells were transfected with 
expression vectors for GFP-CnAβ1 or GFP-CnAβ1-mut. Cells were lysed and GFP 
chimeras were immunoprecipitated (IP) with anti-GFP. Co-immunoprecipitation of 
mTOR was determined by western blot using anti-mTOR. Similar expression of 
mTOR in both conditions is shown in total lysates for reference.  
 
Figure 6 Cog8 interacts with CnAβ1 and mediates its localization in the Golgi 
apparatus. (A) P19 cells were transfected with expression vectors for GFP-CnAβ1 
or GFP-CnAβ1-mut. Cells were lysed and GFP chimeras were immunoprecipitated 
(IP) with anti-GFP. Co-immunoprecipitation of Cog8 was determined by western 
blot using anti-Cog8. Equal expression of Cog8 in both conditions is shown in total 
lysates for reference. (B) P19 cells were transfected with an expression vector for 
GFP-CnAβ1. Colocalization with Cog8 (red) was analyzed by immunofluorescence. 
Nuclei were counterstained with DAPI (blue). Bar, 10 μm. (C) P19 cells were 
transfected with control or Cog8 siRNAs together with a GFP-CnAβ1 expression 
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vector. Localization of GFP-CnAβ1 (green), Cog8 (red), GM130 (white) were 
determined by immunofluorescence. Bar 10 μm. (D, E) The downregulation of 
COG8 protein after siRNA transfection was confirmed by western blot (D) and 
quantified (E). *p<0.05, **p<0.01, one-way ANOVA, n=3. 
 
Figure 7. Cog8 knockdown inhibits mesoendoderm differentiation.  
mESCs were transiently transfected with two different siRNAs for Cog8 or a control 
siRNA and differentiated towards mesoderm by using EBs. (A-D) RNA was 
extracted at different days of differentiation and Cog8, BraT, Gsc and Eomes were 
analyzed by qRT-PCR. Results are presented as fold induction ±SEM over the 
values for undifferentiated stem cells. *p<0.05, ***p<0.001, two-way ANOVA with 
Bonferroni post-test, n=3. 
 
Figure 1 Click here to download Figure Gomez-Salinero Fig1.tif 
Figure 2 Click here to download Figure Gomez-Salinero Fig2.tif 
Figure 3 Click here to download Figure Gomez-Salinero Fig3.tif 
Figure 4 Click here to download Figure Gomez-Salinero Fig4.tif 
Figure 5 Click here to download Figure Gomez-Salinero Fig5.tif 
Figure 6 Click here to download Figure Gomez-Salinero Fig6.tif 
Figure 7 Click here to download Figure Gomez-Salinero Fig7.tif 
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Figure S1. Related to Fig. 1. CnAβ1 is not required for the maintenance of pluripotency. (A) RNA from 
mESCs transfected with a control siRNA or two different CnAβ1 siRNAs in pluripontent conditions was 
isolated 2 days after transfection and CnAβ1 was analyzed by qRT-PCR. (B, C) Cells were transfected as in 
(A) and protein was isolated, analyzed by western blot (B) and the bands were quantified (C). (D-K) The 
expression of the CnA isoforms CnA, CnA and CnA2 (D-F) and the pluripotency related genes Oct3/3, 
Klf4, Sox2, Gbx2 and Stella (G-K) was analyzed by qRT-PCR in pluripotent mESCs transfected as in (A). 
**p<0.01, one-way ANOVA plus Dunnett's post-test, n=3. 
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Figure S2. Related to Fig. 1. CnA2 expression is induced during mesodermal and ectodermal 
differentiation. (A, B) The expression of CnA2 was analyzed by qRT-PCR in mESCs differentiating either 
to mesoderm (A) or ectoderm (B).  
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Figure S3. Related to Fig. 2. CnA1 is necessary for mESC differentiation to mesoderm. (A) mRNA 
expression of selected genes from mESCs transfected with two different CnAβ1 siRNAs was measured by 
microarray analysis and compared to cells transfected with a control siRNA. Values are shown as Log2 fold 
induction ±SEM, n≥2. (B) Changes observed in the microarray experiment were validated by qRT-PCR for 
Brachyury T, Eomes, Fgf8 and Foxa2. *p<0.05, **p<0.01, ***p<0.005, one-way Anova plus Dunnett's post-
test, n=3. (C) The proliferation capacity of mESCs differentiated to mesoderm after CnAβ1 knockdown was 
measured by their incorporation of BrdU during 4 h on the second day of differentiation. The absorbance values 
were normalized to the number of EBs per condition. Results are presented as absorbance ±SEM. Differences 
were not statistically significant, one-way ANOVA with Dunnett’s post-test, n=6.  
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Figure S4. Related to Fig. 3. CnAβ2 knockdown inhibits mesoendoderm differentiation. mESCs were 
transiently transfected with two different siRNAs for CnAβ2 or a control siRNA and differentiated towards 
mesoderm by using EBs for 6 days. (A-J) RNA was extracted at different days of differentiation and CnAβ2, 
CnAβ1, BraT, Eomes, Mesp1, Sox17, Sox2, Nestin, CnA (Ppp3ca) and CnA (Ppp3cc) were analyzed by 
qRT-PCR. Results are presented as fold induction ±SEM over the values for undifferentiated stem cells. 
**p<0.01, ***p<0.005, two-way ANOVA with Bonferroni post-test (A-H), n=3.  
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Figure S5. Related to Fig. 3. CnAβ2 knockdown and inhibition of the catalytic activity of CnA have no 
effect on the AKT/GSK3/-catenin pathway. (A, B) Cells were transfected with a control siRNA or wo 
independent siRNAs against CnA2 (A, B) or treated with 200 ng/mL cyclosporin A (CsA) (B, D), allowed to 
differentiate for 2 days towards mesoderm and p-AKT S473, total AKT, p-GSK3β S9, total GSK3β, β-catenin 
and β-actin were analyzed by western blot. Band quantification is shown in (B and D). (E) Cells were 
differentiated in the presence or absence of 200 ng/mL CsA and the expression of differentiation markers was 
determined by qRT-PCR at day 4 of differentiation. *p<0.05, **p<0.01, unpaired t-test, n=3. 
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Figure S6. Related to Fig. 5. CnAβ1 structure prediction has two evolutionarily conserved α-helixes. (A, 
B) The secondary structure of CnAβ1 and CnAβ2 was predicted using Psipred. Cylinders in pink indicate -
helices. The small blue bars indicate conservation. (C) Clustal analysis of CnA1’s C-terminal domain 
conservation between Xenopus laevis, Anolis carolinensis, Gallus gallus, Mus musculus and Homo sapiens. 
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Table S1. Related to Fig. 1. Differentially expressed genes in mESCs 2 days after transfection with CnAβ1 
siRNAs in pluripotent conditions. Total RNA was isolated from pluripotent mESCs transfected with CnAβ1 
or control siRNAs 48 h after transfection and gene expression was analyzed by microarray. Values show linear 
fold induction compared to the control siRNA. Negative sign indicates inhibition. Genes with significant 
changes >1.4-fold are shown. 
    
Affymetrix ID 
Fold  
CnAβ1 (1) vs 
Control 
Fold  
CnAβ1 (2) vs  
Control 
Gene Name 
10408593 1.51 1.45 Serpinb6c 
10423570 1.82 1.47  
10450930 1.40 1.43 Crisp1 
10557853 1.42 1.51 B230325K18Rik 
10584315 1.49 1.44  
10604154 -1.48 -1.49 Rhox9 
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Table S2. Related to Fig. 2. Differentially expressed genes in embryoid bodies after CnAβ1 knockdown. 
mESCs were transfected with control or CnAβ1 siRNA and induced to differentiate. Gene expression was 
analyzed 48 h later using microarrays. Values show linear fold induction compared to the control siRNA. 
Negative sign indicates inhibition. Genes with significant changes >2.0-fold are shown. 
    
Affymetrix ID 
Fold  
CnAβ1 (1) vs Control  
Fold   
CnAβ1 (2) vs Control 
Gene Name 
A_52_P382149 -1.10 -2.45 Cyp26a1 
A_55_P2040951 -3.01 -3.06 Actc1 
A_51_P371051 -1.09 -2.30 Glipr1 
A_55_P2399878 -1.47 -2.17 4930402F11Rik 
A_51_P404193 -1.35 -2.54 Sp5 
A_51_P124254 -1.51 -2.31 Col4a1 
A_55_P1957198 -1.08 -2.17 Apob 
A_55_P2134236 -1.26 -2.90 Foxa2 
A_55_P2029161 -1.40 -2.01 T 
A_55_P2032272 -1.35 -2.42 Habp2 
A_51_P476018 -1.22 -2.24 Sox7 
A_51_P343350 -1.13 -2.01 Amn 
A_51_P411917 -1.31 -2.32 Gata6 
A_52_P447284 -1.00 -2.13 Clic6 
A_55_P2152547 -2.95 -2.64 Myl3 
A_52_P473966 -1.28 -2.02 Kdelr3 
A_55_P2102449 -1.22 -2.31 Nxf7 
A_55_P2108109 -1.67 -2.70 Fgf8 
A_52_P51078 -1.01 -3.07 Ctsh 
A_55_P2111163 -1.45 -3.92 S100g 
A_55_P2013236 -1.40 -3.92 S100g 
A_55_P2157023 -1.34 -2.05 Sox17 
A_55_P1983448 -2.23 -1.33 S100a4 
A_52_P300451 -1.41 -2.10 Tcf23 
A_55_P2047639 -1.34 -2.37 Cubn 
A_55_P2184434 -1.39 -2.09 Eomes 
A_51_P491350 -1.61 -2.37 Col4a2 
A_55_P2046877 -1.10 -2.02 Foxq1 
A_55_P2318584 -1.19 -2.62 Aqp8 
A_55_P2026405 -1.25 -2.05 Foxb1 
A_55_P1979833 -1.25 -2.05 Cited1 
A_51_P370717 -1.30 -2.31 Gsc 
A_55_P2101508 -1.76 -2.56 Fgf8 
A_55_P2071349 -1.49 -2.09 Trh 
A_55_P2047638 -1.32 -2.31 Cubn 
A_66_P114804 2.17 1.42 Gm7325 
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A_55_P2123502 2.38 1.33 Jam2 
A_55_P1977943 1.69 2.26 Insm1 
A_55_P2010066 2.18 1.57 Capn3 
A_55_P2111563 2.04 1.72  
A_52_P367760 2.07 1.84 Calml4 
 
 
Table S3. Related to Fig. 2. Gene Ontology analysis after CnAβ1 knockdown in embryoid bodies. Gene 
Ontology analysis of genes downregulated 48 h after CnAβ1 inhibition. Only gene lists with p≤0.05 are shown. 
 
Gene Ontology Nº Genes P-value 
chordate embryonic development  7 9.20E-05 
embryonic development ending in birth or egg hatching  7 9.70E-05 
muscle organ development  4 4.00E-03 
regulation of transcription  11 4.20E-03 
blood vessel morphogenesis  4 5.50E-03 
dorsal/ventral pattern formation  3 6.10E-03 
regionalization  4 6.90E-03 
tissue morphogenesis  4 9.20E-03 
embryonic organ development  4 9.50E-03 
blood vessel development  4 9.80E-03 
vasculature development  4 1.00E-02 
in utero embryonic development  4 1.30E-02 
lipoprotein transport  2 1.30E-02 
pattern specification process  4 1.50E-02 
lung development  3 1.80E-02 
respiratory tube development  3 1.80E-02 
respiratory system development  3 2.20E-02 
embryonic morphogenesis  4 2.70E-02 
dorsal/ventral neural tube patterning  2 2.90E-02 
transcription  8 3.60E-02 
forebrain development  3 3.70E-02 
positive regulation of cell differentiation  3 4.10E-02 
neural tube patterning  2 4.30E-02 
regulation of transcription, DNA-dependent  7 4.60E-02 
negative regulation of Wnt receptor signalling pathway  2 4.70E-02 
regulation of RNA metabolic process  7 4.90E-02 
cardiac muscle cell differentiation  2 5.00E-02 
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Table S4. Related to Fig. 6. Yeast Two Hybrid Screening. Clones with potential CnAβ1 interacting 
proteins are shown. 
 
Gene Protein code Name 
Npm1 NM_012992 Rattus norvegicus nucleophosmin 1 (Npm1), mRNA 
Ldhb NM_012595 Rattus norvegicus lactate dehydrogenase B (Ldhb), mRNA 
Flna XM_238167 PREDICTED: Rattus norvegicus filamin, alpha 
Sep15 NM_133297 Rattus norvegicus selenoprotein (Sep15), mRNA 
Sep15 NM_133297 Rattus norvegicus selenoprotein (Sep15), mRNA 
MT-Cyb AB033713 Rattus norvegicus mitochondrial gene for cytochrome b, partial cds 
Pgk1 BC063161 Rattus norvegicus phosphoglycerate kinase 1, mRNA 
Tax1bp1 NM_001004199  
Rattus norvegicus Tax1 (human T-cell leukemia virus type I) 
binding protein 1 (Tax1bp1), mRNA 
Sorbs1 XM_001154712 
PREDICTED: Pan troglodytes sorbin and SH3 domain containing 
1, transcript variant 10 (SORBS1), mRNA 
Sorbs1 XM_001154933  
PREDICTED: Pan troglodytes sorbin and SH3 domain containing 
1, transcript variant 14 (SORBS1), mRNA 
Sorbs1 XM_001155148  
PREDICTED: Pan troglodytes sorbin and SH3 domain containing 
1, transcript variant 18 (SORBS1), mRNA 
Cap  AJ489942 Homo sapiens mRNA for c-Cbl associated protein (CAP gene). 
Nedd4 NM_012986 
Rattus norvegicus neural precursor cell expressed, 
developmentally down-regulated gene 4 (Nedd4), mRNA 
Mdh1 NM_033235 
Rattus norvegicus malate dehydrogenase 1, NAD (soluble) 
(Mdh1), mRNA 
Cbx3 NM_001008313  
Rattus norvegicus chromobox homolog 3 (HP1 gamma homolog, 
Drosophila) (Cbx3), mRNA 
Tpd52 XR_031313 
Mus musculus similar to Tpd52 protein (LOC100045143), misc 
RNA 
Tfg NM_001012144 Rattus norvegicus Trk-fused gene (Tfg), mRNA 
Cog8 NM_001106182  
Rattus norvegicus component of oligomeric golgi complex 8 
(predicted) (Cog8_predicted), mRNA 
Gapdh NM_017008 
Rattus norvegicus glyceraldehyde-3-phosphate dehydrogenase 
(Gapdh), mRNA 
Ptgis NM_031557 
Rattus norvegicus prostaglandin I2 (prostacyclin) synthase (Ptgis), 
mRNA. 
Smpd1 NM_001006997  
Rattus norvegicus sphingomyelin phosphodiesterase 1, acid 
lysosomal (Smpd1), mRNA 
Tnfrsf1a BC086413 
Rattus norvegicus tumor necrosis factor receptor superfamily, 
member 1a, mRNA (cDNA clone MGC:105478 
IMAGE:7110094), complete cds 
Col1a1 NM_053304 Rattus norvegicus procollagen, type 1, alpha 1 (Col1a1), mRNA 
App XM_001075993 
PREDICTED: Rattus norvegicus similar to Amyloid beta (A4) 
precursor-like protein 1 (predicted), transcript variant 
1(RGD1561211_predicted), mRNA. 
Dhdds NM_001011978  
Rattus norvegicus dehydrodolichyl diphosphate synthase (Dhdds), 
mRNA 
Gpnmb NM_133298 
Rattus norvegicus glycoprotein (transmembrane) nmb (Gpnmb), 
mRNA 
Anxa5 AF051895 Rattus norvegicus lipocortin V mRNA, partial cds 
Anxa5 NM_013132 Rattus norvegicus annexin A5 (Anxa5), mRNA 
Emilin1 NM_001106710  
Rattus norvegicus elastin microfibril interfacer 1 (predicted) 
(Emilin1_predicted), mRNA 
Rpsa NM_017138 Rattus norvegicus ribosomal protein SA (Rpsa), mRNA 
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Rasd1 XM_340809 
PREDICTED: Rattus norvegicus RAS, dexamethasone-induced 1 
(Rasd1), mRNA 
Rtn3 NM_001009953 Rattus norvegicus reticulon 3 (Rtn3), transcript variant 2, mRNA 
Mdh2 NM_031151 
Rattus norvegicus malate dehydrogenase 2, NAD (mitochondrial) 
(Mdh2), mRNA 
Myl6 BC126064 
Rattus norvegicus myosin, light polypeptide 2, regulatory, cardiac, 
slow, mRNA (cDNA clone MGC:156486 IMAGE:7190683), 
complete cds 
Rpl3 NM_198753 Rattus norvegicus ribosomal protein L3 (Rpl3), mRNA 
Ppp3r1/CnB NM_017309 
Rattus norvegicus protein phosphatase 3, regulatory subunit B, 
alpha isoform (calcineurin B, type I) (Ppp3r1), mRNA 
Galnt2 NM_139272 
Mus musculus UDP-N-acetyl-alpha-D-galactosamine:polypeptide 
N-acetylgalactosaminyltransferase 2 (Galnt2), mRNA 
Arhgef6 NM_152801 
Mus musculus Rac/Cdc42 guanine nucleotide exchange factor 
(GEF) 6 (Arhgef6), mRNA 
Gpx7 NM_001106673 
Rattus norvegicus glutathione peroxidase 7 (predicted) 
(Gpx7_predicted), mRNA 
Suclg2 XM_001074572  
PREDICTED: Rattus norvegicus succinate-Coenzyme A ligase, 
GDP-forming, beta subunit, transcript variant 4 (Suclg2), mRNA 
Sdc4 M81786 Rattus norvegicus ryudocan mRNA, complete cds 
Sdc4 NM_012649 Rattus norvegicus syndecan 4 (Sdc4), mRNA 
Aco2 NM_024398 Rattus norvegicus aconitase 2, mitochondrial (Aco2), mRNA 
Cd59 NM_012925 Rattus norvegicus CD59 antigen (Cd59), mRNA 
Mrpl45 NM_001105834  
Rattus norvegicus mitochondrial ribosomal protein L45 (predicted) 
(Mrpl45_predicted), mRNA 
Rbms2 NM_031643 
Rattus norvegicus mitogen activated protein kinase kinase 1 
(Map2k1), mRNA 
Rbms2 NM_001025403 
Rattus norvegicus RNA binding motif, single stranded interacting 
protein 2 (Rbms2), mRNA 
Htt U18650 Rattus norvegicus Huntington gene product mRNA, complete cds 
Tubb NM_001109119  Rattus norvegicus similar to tubulin, beta 2 (LOC498736), mRNA 
Mgat4b BC031613 
Mus musculus mannoside acetylglucosaminyltransferase 4, 
isoenzyme B, mRNA (cDNA clone MGC:36850 
IMAGE:4216720), complete cds 
Col5a1  NM_134452 Rattus norvegicus procollagen, type V, alpha 1 (Col5a1), mRNA 
Bnip3 NM_053420 
Rattus norvegicus BCL2/adenovirus E1B 19 kDa-interacting 
protein 3 (Bnip3), mRNA 
Hspa8 NM_024351 Rattus norvegicus heat shock protein 8 (Hspa8), mRNA 
Uqcrc1 NM_001004250 
Rattus norvegicus ubiquinol-cytochrome c reductase core protein 1 
(Uqcrc1), mRNA 
Decr1 NM_057197 
Rattus norvegicus 2,4-dienoyl CoA reductase 1, mitochondrial  
(Decr1), mRNA 
Whsc2 NM_001008339 
Rattus norvegicus Wolf-Hirschhorn syndrome candidate 2 
(human)  (Whsc2), mRNA 
Whsc2 BC061534 
Rattus norvegicus clusterin, mRNA (cDNA clone MGC:72717  
IMAGE:6886725), complete cds 
Trpm2 M64723 Rat TRPM-2 mRNA, complete cds 
Sgp2 X13231 Rat mRNA for sulfated glycoprotein 2 
Cd81 NM_013087 Rattus norvegicus CD 81 antigen (Cd81), mRNA 
Rab7 NM_023950 
Rattus norvegicus RAB7, member RAS oncogene family (Rab7), 
mRNA 
Tcf4 NM_053369 Rattus norvegicus transcription factor 4 (Tcf4), mRNA 
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Table S5. Related to Experimental procedures. siRNA sequence targeting CnAβ1 and CnAβ2. 
 Name siRNA Sequence 
Control (Luciferase) UUCAUUAUAAAUCUCGUUCGCGGGC 
CnAβ1 (1) AGUUCCUGUCUUAGCAGCUGACAUA 
CnAβ1 (2) GGUGUUUGUCAAACGUUCUAUGUAU 
CnAβ2 (1) GGAGGAUAUCUACACCUCCAUUUAU 
CnAβ2 (2) UGCUGCUGGCUUUGUAUCAUCUUUA 
 
 
Table S6. Related to Experimental procedures. Invitrogen siRNA code targeting Cog8 
Name siRNA code 
Cog8 (1) MSS235216 
Cog8 (2) MSS294762 
 
 
Table S7. Related to Experimental procedures. TaqMan probes used for RT-PCR. 







Table S8. Related to Experimental procedures. Primers for RT-PCR using SyberGreen. 
Gene Primer FW Primer RV 
Brachyury CTCCAACCTATGCGGACAAT CCCCTTCATACATCGGAGAA 
Eomes TTCACCTTCTCAGAGACACAGTTCAT GAGTTAACCTGTCATTTTCTGAAGCC 
Goosecoid ACGAGGGCCCCGGTTCTGTA CACTTCTCGGCGTTTTCTGACTCC 
Sox17 GCGGCGCAAGCAGGTGAAG GGGGCCCATGTGCGGAGAC 
CnA1 ATGCTGTTTCCTTCCTCTGC GACTGAACCAAGTGCAGCAA 
CnA2 CTGAACACCGCACATACCAC CACGGATCTCAGAAAGCACA 
CnA Ex2-3 ATGGGATACCCAGGGTTGAT GCAGGTGATCCTCCTACTTCA 
Wnt3 CAGCGTAGCAGAAGGTGTGA TGGCCCCTTATGATGTGAGT 
Mesp1 TGTACGCAGAAACAGCATCC TTGTCCCCTCCACTCTTCAG 
Nestin CGGAGAGGGAGCAGCACCAA GGCCTCCCCCACAGCATCCT 
Mbnl1 TGCTCCAGAGAGAACTGCAA TAAAGGCTGCTGATGCACTG 
Mbnl2 GCCAGGTTGAAAATGGAAGA GGCGTTCCTGGAAACATAAA 
Foxa2 CATCCGACTGGAGCAGCTA GCGCCCACATAGGATGAC 
Sox7 GGATGAGAGGAAACGTCTGG GCTTGCCTTGTTTCTTCCTG 
Gata6 CTACACAAGCGACCACCTCA CCTCTTGGTAGCACCAGCTC 
Fgf8 CGAAGCTCATTGTGGAGACC TCCAGCACGATCTCTGTGAA 
Stella GTCGGTGCTGAAAGACCCTA GATTTCCCAGCACCAGAAAA 
Gbx2 AGACGGCAAAGCCTTCTTG AGCAGTCTGACCAGGCAAAT 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
 
Cell culture and transfection 
R1 mESCs in pluripotent conditions were grown on irradiated mouse embryonic fibroblast (MEFs) in 
Dulbecco’s modified Eagle medium (DMEM) supplemented with L-glutamine (2 mM), NEAA (1X), β-
Mercaptoethanol (50 μM), 15% high qualified FBS and LIF at 37 ºC in a 5% CO2 atmosphere. mESCs were 
passaged every 2 days in pluripotent conditions using Trypsin (Sigma). For differentiation assays, mESCs were 
trypsinized and cultured first for 1 h under pluripotent conditions in 0.1% gelatin coated dishes to discard MEFs. 
We used the hanging drop method for mesoendoderm differentiation with a cell suspension of 5x104 cell/ml 
(1000 cells per drop in 20 μl) in DMEM supplemented with L-glutamine (2 mM), NEAA (1X), β-
Mercaptoethanol (50 μM) and 20% FBS as previously described (Bondue et al., 2008). On day 2 of 
differentiation the EBs where collected, cultured on an untreated dish for 5 d and further cultured on a 0.1% 
gelatin-coated dish. Neural progenitor cell differentiation was induced using DMEM supplemented with L-
glutamine (2 mM), NEAA (1X), β-Mercaptoethanol (50 μM) and 10% knockout serum replacement (Kamiya 
et al., 2011).  
mESCs were transfected in suspension with Lipofectamine 2000 (Invitrogen) and 10 μM siRNAs (Table S5) or 
1 μg of modified RNA (Bernal, 2013; Pankaj K Mandal and Rossi, 2013) following the manufacturer’s 
instructions. A luciferase siRNA and a GFP modified RNA were used as negative controls, respectively. After 
transfection, cells were collected and differentiated to mesoendoderm or maintained under pluripotent 
conditions. The inhibition of GSK3β was performed as previously described (Lindsley et al., 2006). Briefly 
mESCs were transfected with CnAβ1 or control siRNAs and differentiated in EBs. At day 2 of differentiation 
20 μM LiCl was added for 8 h in differentiation medium to inhibit GSK3β. Cells were then changed to normal 
differentiation medium. The expression of the differentiation markers was analyzed at day 4 and compared to 
its expression in the control cells.  The inhibition of calcineurin was performed using Cyclosporin A (CsA) at 
200 ng/mL. Cells were differentiated on the presence or absence of CsA on the second day of differentiation 
for 8 hours and analyzed by western blot or differentiated until day 4 on the presence or absence of CsA and 
the expression of the differentiation markers was analyzed. 
P19 cells were maintained in DMEM supplemented with L-glutamine (2 mM), β-Mercaptoethanol (50 μM) and 
10% FBS. P19 cells were transfected in suspension with Lipofectamine 2000 on 1% gelatin-coated coverslips 
following the manufacturer’s instructions. Cells were fixed in 4% paraformaldehyde (PFA) 24 h after 
transfection. To study the localization of CnAβ1 after Cog8 knockdown, we transfected the cells for 2 days 
with Cog8 siRNAs (Table S6) to downregulate its expression, and then transfected the GFP-CnAβ1 construct. 
Cells were fixed 6 h post-transfection and immunostained for GFP, Cog8 and GM130 using specific antibodies. 
 
RNA isolation and qRT-PCR  
Total RNA was isolated from mESCs with RNeasy Mini Kit (Qiagen). First-strand cDNA was synthesized 
using 100 ng total RNA and a High Capacity cDNA Reverse Transcription kit (Applied Biosystems). The 
cDNA was amplified using the primers described in Table S7. Quantitative RT-PCR was carried out in an 
Applied Biosystems 7900 Fast real-time PCR system (Applied Biosystems) using SYBR green for double-
stranded DNA detection and quantification or TaqMan probes as indicated in Table S7, S8. Results were 
analyzed with LinReg PCR software (Ruijter et al., 2013). Values were normalized to GAPDH or 18S TaqMan 
probes. 
   
CLIP-Seq Analysis and RNA-Seq alignment 
Bed file alignments from the GSE39911 dataset were downloaded from Gene Expression Omnibus (GEO) and 
aligned to the mm9 genome using IGV software. The localization of the Mbnl1 binding sites in CnAβ (Ppp3cb) 
was identified in C2C12 myoblasts, C57/Bl6 heart, muscle and brain samples. Raw sequencing data for brain, 
heart, and muscle samples from wild-type mice (5 replicates per tissue) and C2C12 mouse myoblasts (single 
control sample) were retrieved from the NCBI Short Read Archive (SRA study accession number SRP014709) 
and converted to FASTQ using fastq-dump in SRA Toolkit version 2.3.3-2. Reads were aligned with TopHat2 
version 2.0.12 to the GRCm38 mouse genome using available transcript annotations from Ensembl release 76 
(Gatto A et al., 2014). For paired-end data (C2C12 control sample) the mean insert size and standard deviation 
were computed empirically from uniquely mapping, perfect matching mate pairs via a preliminary alignment 
with Bowtie2 version 2.2.3 and supplied as input parameters to TopHat2. Default options were used otherwise. 
Regulation of mesoderm specification by CnAβ1 Gómez-Salinero et al. 
Supplementary Information Page 14 of 16 
Reads mapping to the genomic location spanning the last four exons of the calcineurin gene (chromosome 14: 
20,499,364-20,509,500 reverse strand) were retrieved after sorting and indexing the corresponding BAM files 
with samtools version 1.0 (Li H et al., 2009). Custom Python scripts were used to compute per-base coverage, 
normalize raw counts to the maximum over the specified region and plot the relative read distribution (median 
over 5 replicates in tissue samples) against calcineurin terminal exons. 
 
Microarray Analysis  
mESCs were transfected with siRNAs against CnAβ1 or a control siRNA targeting luciferase and analyzed 48 
h later in pluripotent or differentiation conditions. Microarray analysis was performed on 8 samples: 3x control 
siRNA, 3x CnAβ1 siRNA #1 and 2x CnAβ1 siRNA #2. Labelling and hybridization to Affymetrix Mouse Gene 
1.0 ST Arrays (Mouse) for mESCs in pluripotent conditions, or Agilent Whole Mouse Genome Microarray 
4x44K v2 for mESCs in differentiation conditions was carried out at CNIC Genomics Unit. Normalization and 
analysis of the data were performed using GeneSpring software. Gene Ontology (GO) analysis was performed 
using David Bioinformatics. GO results were considered significant at p<0.05. The entirety of the Microarray 
data set has been supplied to the Gene Expression Omnibus public database (Series GSE72103).  
 
Cell proliferation assay  
mESCs were transfected and differentiated to mesoendoderm in EBs. After 48 h of differentiation, EBs were 
collected and cultured with BrdU for 4 h in differentiation medium. EBs were then collected in groups of 3 and 
placed in a 24-well plate. BrdU incorporation was determined following manufacturer’s instructions. EBs 
untreated with BrdU and cell-free wells treated with BrdU were used as negative controls.  
 
Western Blot  
EBs were homogenized in lysis buffer (150 mM NaCl, 1% IGEPAL, 0.5% sodium deoxycholate, 0.1% SDS, 
and 50 mM Tris pH 8.0) in the presence of protease and phosphatase inhibitors (04693159001 and 04906845001 
Roche Diagnostics). EB lysates were separated in SDS-PAGE gels, transferred to PVDF membranes and 
blocked with 3% non-fat dry milk in PBS for 30 min. The membranes were incubated with primary antibodies 
overnight, followed by appropriate HRP-labelled secondary antibodies (anti-mouse P0447 and anti-rabbit 
P0448, Dako). HRP activity was detected using a luminol-based reagent (RPN 2106, GE Healthcare). Primary 
antibodies: AKT (4691 Cell Signaling), p-AKT S473 (4058 Cell Signaling), GSK3β (9315 Cell Signaling), p-
GSK3β (9323 Cell Signaling), β-actin (A5316 Sigma), β-catenin (9562 Cell Signaling)., CnAβ1 (from our 
laboratory), Cog8 (PA5-29126, Thermo), Vinculin (V4505, Sigma), Integrin 1 (MA1997, Millipore), RhoGDI 
(sc360, Santa Cruz), p-MTOR S2481 (2971 Cell Signaling), MTOR (2983 Cell Signaling), GM130 (bd610823 
BD Biosciences), Rictor (ab56578 Abcam). Western blot quantification has been performed on ImageJ 
software. Brightness and contrast were linearly adjusted in Adobe Photoshop CS5.  
 
Luciferase assay 
mESCs were lysed in 1X passive lysis buffer (Promega) and homogenized for 15 min at room temperature. 
Luciferase was measured following the manufacturer’s instructions (Promega) and normalized for transfection 
efficiency with Renilla luciferase. As a negative control, we used the same reporter plasmid with the TCF sites 
mutated (FOP-Luc) and expressed the results as the ratio of luciferase activity obtained with the TOP-Luc 
divided by the activity of the FOP-Luc.  
 
Cytoplasm and membrane fractionation 
Cells were cultured under differentiation conditions and analyzed on the second day of differentiation. For the 
purification of enriched cytoplasmic or membrane fractions, the embryoid bodies were collected in PBS in the 
presence of protease and phosphatase inhibitors (04693159001 and 04906845001 Roche Diagnostics). Cells 
were then lysed in a homogenizer and centrifuged for 5 minutes at 3,000 g to remove the nuclei. The supernatant 
was centrifuged at 200,000 g to separate the membranes (pellet) from the cytoplasm (supernatant). Both 
fractions were analyzed by a western blot to verify their purity using antibodies against RhoGdI for the 
cytoplasm and against GM130 and integrin β1 for the membranes. 
 
Protein structure prediction  
The structure of CnAβ1 was predicted using the Psipred software. The evolutionary conserved regions of 
CnAβ1 were predicted by comparing the aminoacid sequence of its C-terminal domain from Xenopus laevis, 
Anolis carolinensis, Gallus gallus, Mus musculus and Homo sapiens on CLUSTAL.  
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DNA constructs  
pEGFP-CnAβ1, CnAβ2, the C-ter region of CnAβ1 and CnAβ2 and -helixes 1 and 2 of CnAβ1 were amplified 
by PCR using KAPA HiFi HotStart Ready Mix PCR kit (Kapa Biosystems) from pCDNA3.1-based CnAβ1 
and CnAβ2 constructs (Lara-Pezzi et al., 2007) and inserted into pGEM-T vector. After the integrity of the 
constructs was confirmed by DNA sequencing they were cloned into the pEGFP.C3 vector in frame with GFP. 
The localization mutant CnAβ1-mut carries the following aminoacid mutations: ACREFLL > VSKDLFF. 
Modified mRNAs (modRNAs) were cloned and produced as previously described (Pankaj K Mandal and Rossi, 
2013). Briefly the CDS of GFP (negative control), CnA1 or CnA1-mut were fused to a 3’ and a 5’ UTR that 
highly promote their expression, synthesized in vitro and purified.  
 
Immunofluorescence  
P19 cells were transfected with the different GFP constructs and grown over-night on 1% gelatin-coated glass. 
Cells were fixed with 4% PFA/PBS for 10 min at 4 ºC, washed with PBS, permeabilized for 10 min with 0.1% 
Triton X-100/PBS and incubated in 10% Goat Serum/PBS for 30 min at room temperature. Cells were incubated 
overnight in 10% Goat Serum/PBS with anti-GFP (632592, Clontech (rabbit) or, 1010/0511FP12, Aves lab 
(chicken)), anti-GM130 (610823, BD Bioscience) or anti-Cog8 (PA5-29126, Thermo). After primary antibody 
incubation, cells were washed with PBS, incubated with Alexa Fluor 488 goat anti-rabbit IgG (A-11034, 
Thermo), Alexa Fluor 568 goat anti-mouse IgG (A-11004, Thermo), Alexa Fluro 488 goat anti-chicken IgG 
(A-11039, Thermo), Alexa Fluor 568 goat anti-rabbit IgG (A-11036, Thermo) or Alexa Fluor 633 goat anti-
mouse IgG (A-21126, Thermo) in 10% Goat Serum/PBT for 1 h at room temperature, and mounted in 
Vectashield Mounting medium with DAPI. Images were acquired in a Leica SPE3 confocal coupled to a DM 
2500 microscope with an objective ACS APO 63.0X 1.13 OIL at 20ºC. The software used to acquire the images 
was LAS AF V 4.0.0 11706. The Manders’ correlation coefficient was calculated on ImageJ software 
performing the total green channel (GFP) over the red channel (GM130). Images were amplified and brightness 
and contrast were linearly adjusted using Adobe Photoshop CS5.  
 
Yeast two hybrid Assay 
Yeast two-hybrid screening was performed using the GAL4 Two-Hybrid phagemid vector kit (Stratagene) and 
used to identify novel protein-protein interactions with CnA1 by screening a cDNA library prepared from rat 
neonatal cardiomyocyte (RNCM) mRNA.  DNA encoding CnA1 was inserted in to pBD-GAL4 to construct 
the bait plasmid, which was verified by sequencing and Western blot.  A library of target plasmids was 
constructed by preparing DNA inserts from NRCM cDNA and ligating these into pAD-GAL4-2.1.  The bait 
and target plasmids were co-expressed in the yeast host, YRG-2 strain. Colonies that contained DNA encoding 
target proteins, which interact with the bait protein, were identified by transcription of the HIS3 and LacZ 
reporter genes in the yeast host strain.  Plasmids were isolated from 111 positive clones and sequenced. Table 
S4 shows the protein identity and common names for the 62 clones that were found to be in frame with a known 
protein product. 
 
Statistical analysis  
All data are presented as mean ±SEM. All datasets were analyzed for statistical significance using 1-way 
ANOVA followed by Dunnett's post-test for multiple comparisons or 2-way ANOVA followed by Bonferroni's 
post-test (GraphPad Prism), as indicated in the figure legends. Changes were represented as statistically 
significant at p<0.05. 
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